GERN trade ideas
$GERN Geron Corp. Breakout Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
$GERN MASSIVE MOVE EXPECTED ON JUNE 15TH DATA RELEASE If you fancy a flutter, GERN could be a great place to start, option traders are expecting a move of up to $40 % on Monday as a result of the outcome from the Phase Data results been released tomorrow at the HOC conference. Like any Bio stock it is risky to trade but can be very rewarding,so play carefully.
AVERAGE ANALYSTS PRICE TARGET $3.5
AVERAGE ANALYSTS RECOMMENDATION BUY
SHORT INTEREST 25%
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
$GERN Geron Group up 100% in 2019 and continues to gain.Geron Group has been on a explosive move forward in 2019 and like many Pharmaceutical companies it is moving on very little publicly released news. We have a alert on the stock for a break of $2.40 where it meets resistance and the 200ma with a major gap above.
GERN - bad newsGERN dropped very badly in premarket today because of some bad news involving Johnson & Johnson's (NYSE:JNJ) Janssen unit. I was curious to see if there was any insider trading in the days before the news was released. I found out there were two transactions, both of the director and the secretary sold a total of $7 million dollars in late August - middle September. Usually when a single insider sells shares, it can be for many various reasons - not necessarily because they expect the price to drop. But when there are more than one sellers and they both sell significant amounts, it should be a question mark for investors. Now the price is $2.40 and I don't know if they will go up or down from here. I consider they have the right to do whatever is in their best interest with their shares and if the company happens to have bad news, it's ok to sell their shares - they did the right thing and they filed their trades in the same day.
GERN to 5.50 / 6.00 based on a Boiler-room style Pitch Calli got a Sales Pitch call "Belford Style" which resembled basically the Wolf of Wallstreet Sales and the "Boileroom Closer" in a single phone conversation.
the call happend while i was trading the markets live, and happend to record a few bits out of it.
here is a small cutout of it on Youtube: youtu.be
so this Idea serves as a reminder of the call is become true or not.
the target price of 6$ should be reached before end of November 2018